Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

ClinicalTrials.gov ID: NCT00118898

Public ClinicalTrials.gov record NCT00118898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 7:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects

Study identification

NCT ID
NCT00118898
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Network
Enrollment
1,864 participants

Conditions and interventions

Conditions

Interventions

  • Abacavir/Lamivudine Drug
  • Atazanavir Drug
  • Efavirenz Drug
  • Emtricitabine/Tenofovir disoproxil fumarate Drug
  • Ritonavir Drug
  • Abacavir/Lamivudine placebo Drug
  • Emtricitabine/Tenofovir disoproxil fumarate placebo Drug

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Oct 31, 2009
Completion
Oct 31, 2009
Last update posted
Oct 11, 2018

2005 – 2009

United States locations

U.S. sites
51
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Usc Crs (1201) Los Angeles California 90033
UCLA CARE Center CRS (601) Los Angeles California 90035
Stanford CRS (501) Palo Alto California 94304
Ucsd, Avrc Crs (701) San Diego California 92103
Ucsf Aids Crs (801) San Francisco California 94110
San Mateo County AIDS Program (505) Stanford California 94305-5107
Willow Clinic (507) Stanford California 94305-5107
Harbor-UCLA Med. Ctr. CRS (603) Torrance California 90502
University of Colorado Hospital CRS (6101) Aurora Colorado 80045
Georgetown University CRS (GU CRS) (1008) Washington D.C. District of Columbia 20007
University of Miami AIDS CRS (901) Miami Florida 33139
Emory University Atlanta Georgia 30308
The Ponce de Leon Center CRS (5802) Atlanta Georgia 30308
Northwestern University CRS (2701) Chicago Illinois 60611
Cook County Hospital Core Center (2705) Chicago Illinois 60612
Rush Univ. Med. Ctr. ACTG CRS (2702) Chicago Illinois 60612
Indiana University Hospital (2601) Indianapolis Indiana 46202-5250
Wishard Hospital (2603) Indianapolis Indiana 46202
Univ of Iowa Hosp and Clinic (1504) Iowa City Iowa 52242
IHV Baltimore Treatment CRS (4651) Baltimore Maryland 21201
Johns Hopkins Adult AIDS CRS (201) Baltimore Maryland 21287
Massachusetts General Hospital ACTG CRS (101) Boston Massachusetts 02114
Brigham and Women's Hosp. ACTG CRS (107) Boston Massachusetts 02115
Bmc Actg Crs (104) Boston Massachusetts 02118
Beth Israel Deaconess Med. Ctr., ACTG CRS (103) Boston Massachusetts 02215
Washington U CRS (2101) St Louis Missouri 63110
SUNY - Buffalo (Rochester) (1102) Buffalo New York 14215
Cornell CRS (7804) New York New York 10011
Weill Med. College of Cornell Univ., The Cornell CTU -Chelsea (7803) New York New York 10011
NY Univ. HIV/AIDS CRS (401) New York New York 10016
HIV Prevention & Treatment CRS (30329) New York New York 10032
Harlem ACTG CRS (31483) New York New York 10037
AIDS Community Health Ctr. ACTG CRS (1108) Rochester New York 14604
University of Rochester ACTG CRS (1101) Rochester New York 14642
Unc Aids Crs (3201) Chapel Hill North Carolina 27514
Wake County Department of Health (30076) Chapel Hill North Carolina 27514
Duke University Medical Center Adult CRS (1601) Durham North Carolina 27710
Moses H. Cone Memorial Hospital CRS (3203) Greensboro North Carolina 27401
University of Cincinnati CRS (2401) Cincinnati Ohio 45267
Case CRS (2501) Cleveland Ohio 44106
Metro Health CRS (2503) Cleveland Ohio 44109
The Ohio State Univ. AIDS CRS (2301) Columbus Ohio 43210
Presbyterian Medical Center - Univ. of PA (6206) Norristown Pennsylvania 19401
Hosp. of the Univ. of Pennsylvania CRS (6201) Philadelphia Pennsylvania 19104
Pitt CRS (1001) Pittsburgh Pennsylvania 15213
The Miriam Hosp. ACTG CRS (2951) Providence Rhode Island 02906
Vanderbilt Therapeutics CRS (3652) Nashville Tennessee 37232
Peabody Health Center CRS (31443) Dallas Texas 75215
University of Texas, Galveston (6301) Galveston Texas 77555-0435
University of Washington AIDS CRS (1401) Seattle Washington 98104
University of Washington General Clinical Research (1403) Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00118898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00118898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →